Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Double-blind Comparative Study of BAY 77 1931 (Lanthanum Carbonate) With a Calcium Carbonate in Patients With Hyperphosphatemia Undergoing Hemodialysis

NCT01514851 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT01514851
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01514851 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Double-blind Comparative Study of BAY 77 1931 (Lanthanum Carbonate) With a Calcium Carbonate in Patients With Hyperphosphatemia Undergoing Hemodialysis
Lead sponsor
Bayer
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2006
Completion date
May 31, 2006
Enrollment
259 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

hyperphosphatemia